COVID-19

Longevity of mucosal and systemic SARS-CoV-2 antibodies in South African vs Dutch children with respiratory tract infections

2023

Authors: van Weelden G, Dewandel I, de Jonge MI, Redfern A, Bekker C, Lochan H, van der Gaast C, Van Niekerk M, Mentor M, Mfazwe A, Fröberg J, Diavatopoulos D, Donà D, Rabie H, van der Zalm M, Verhagen LM.

Presented at: International Congress of Immunology (IUIS)

Read More

Comparative study showed that children faced a 78% higher risk of new-onset conditions after they had COVID-19

2023

Authors: Di Chiara C, Barbieri E, Chen YX, Visonà E, Cavagnis S, Sturniolo G, Parca A, Liberati C, Cantarutti L, Lupattelli A, Le Prevost M, Corrao G, Giaquinto C, Donà D, Cantarutti A.

Published in: Acta Paediatrica

Read More

COVID-19 and MIS-C treatment in children—results from an international survey

2023

Authors: Donà D, Minotti C, Masini T, Penazzato M, Van Der Zalm MM, Judd A, Giaquinto C, Lallemant M & Survey Respondents Consortium.

Published in: European Journal of Pediatrics

Read More

Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV

2023

Authors: Ruel T, Penazzato M, Zech JM, Archary M, Cressey TR, Goga A, Harwell J, Landovitz RJ, Lain MG, Lallemant M, Namusoke-Magongo E, Mukui I, Permar SR, Prendergast AJ, Shapiro R, Abrams EJ.

Published in: Global Health: Science & Practice

Read More

The Smooth Away From Expected (SAFE) non-inferiority frontier: theory and implementation with an application to the D3 trial

2023

Authors: Quartagno, M, Chan, M, Turkova, A et al.

Published in: Trials

Read More

Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance

2023

Authors: Botha JC, Byott M, Spyer MJ, Grant PR, Gärtner K, Chen WX, Burton J, Bamford A, Waters LJ, Giaquinto C, et al.

Published in:Viruses

Read More

Minimising school disruption under high incidence conditions due to the Omicron variant in France, Switzerland, Italy, in January 2022

2023

Authors: Colosi E, Bassignana G, Barrat A, Lina B, Vanhems P, Bielicki J, Colizza V.

Published in: MedRxiv (preprint) and Eurosurveillance

Read More

Large-scale cohort research project invites researchers to participate in science challenge

2023

ORCHESTRA opens doors to COVID-19 related data to selected scientists

Verona 17/07/2023 – ORCHESTRA-Cohort is a multinational cohort research project on COVID-19 and its long-term sequelae. The collaborative data collection of SARS-CoV-2 infections including long-term follow-ups aims at creating a precise clinical picture of the disease to contribute to better patient care. External scientists are now welcome to apply to participate in a science challenge carried out with patient data of the EU funded project.

Read More

Evaluation of Waning of SARS-CoV-2 Vaccine-Induced Immunity: A Systematic Review and Meta-analysis

2023

Authors: Menegale F, Manica M, Zardini A, Guzzetta G, Marziano V, D’Andrea V, Trentini F, Ajelli M, Poletti P, Merler S.

Published in: JAMA Network Open

Read More

Clinical Presentation and Outcome of Acute Respiratory Illnesses in South African Children During the COVID-19 Pandemic

2023

Authors: Redfern A, van der Zalm MM, Lishman J, Goussard P, Smit L, Dagan R, Barday M, Mare M, Claassen M, Van Zyl G, Rabie H, Verhagen LM.

Published in: The Pediatric Infectious Disease Journal

Read More

Pediatric coronavirus disease 2019 in Africa

2023

Authors: Van der Zalm MM, Donà D, Rabie H.

Published in: Current Opinions in Pediatrics

Read More

Mid- and Long-Term Atrio-Ventricular Functional Changes in Children after Recovery from COVID-19

2023

Authors: Sabatino J, Di Chiara C, Di Candia A, Sirico D, Donà D, Fumanelli J, Basso A, Pogacnik P, Cuppini E, Romano LR, Castaldi B, Reffo E, Cerutti A, Biffanti R, Cozzani S, Giaquinto C, Di Salvo G.

Published in: Journal of Clinical Medicine

Read More

Early Treatments of Fragile Children with COVID-19—Results of CLEVER (Children COVID Early Treatment), a Retrospective, Observational Study

2023

Authors: Minotti C, Mengato D, De Pieri M, Trivellato S, Francavilla A, Di Chiara C, Liberati C, Mattera R, Biffi A, Giaquinto C, Venturini F, Donà D.

Published in: Viruses

Read More

Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study

2023

Authors: De Meijere G, Valdano E, Castellano C, Debin M, Kengne-Kuetche C, Turbelin C, Noël H, Weitz J, Paolotti D, Hermans L, Hens N, Colizza V.

Published in: The Lancet Regional Health – Europe

Read More

The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts

2022

Authors: Westerhof I, de Hoog M, Ieven M, Lammens C, van Beek J, Rozhnova G, Eggink D, Euser S, Wildenbeest J, Duijts L, van Houten M, Goossens H, Giaquinto C, Bruijning-Verhagen P.

Published in: International Journal of Infectious Diseases

Read More

COVID-19 in Infants Less than 3 Months: Severe or Not Severe Disease?

2022

Authors: Donà D, Montagnani C, Di Chiara C, Venturini E, Galli L, Lo Vecchio A, Denina M, Olivini N, Bruzzese E, Campana A, Giacchero R, Salvini F, Meini A, Ponzoni M, Trapani S, Rossi E, Lombardi MH, Badolato R, Pierri L, Pruccoli G, Rossin S, Colomba C, Cazzato S, Pacati I, Nicolini G, Pierantoni L, Bianchini S, Krzysztofiak A, Garazzino S, Giaquinto C, Castelli Gattinara G

Published in: Viruses

Read More

Controlling SARS-CoV-2 in schools using repetitive testing strategies

2022

Authors: Torneri A, Willem L, Colizza V, Kremer C, Meuris C, Darcis G, Hens N, Libin PJK.

Published in: eLife

Read More

Study reveals moderate effectiveness of Pfizer-BioNTech’s Covid-19 vaccine against Omicron in children aged 5-11

2022

A large study on the effectiveness of the Pfizer-BioNTech’s Covid-19 vaccine in children aged 5-11 was published in The New England Journal of Medicine.

The study was conducted at Israel’s largest healthcare organization, Clalit Health Services, in collaboration with researchers from the University of Padua, Harvard University and University College London.

This is one of the first large observational studies that uses Real-World Data evaluate the effectiveness of the Pfizer-BioNTech BNT162b2 (Comirnaty) vaccine in children aged 5-11 against the Omicron variant.

Read More
1 2 3 6